Amundi’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-64,873
| Closed | -$3.83M | – | 2088 |
|
2023
Q4 | $3.83M | Buy |
64,873
+53,915
| +492% | +$3.18M | ﹤0.01% | 1039 |
|
2023
Q3 | $613K | Sell |
10,958
-2,812
| -20% | -$157K | ﹤0.01% | 1378 |
|
2023
Q2 | $524K | Sell |
13,770
-17,502
| -56% | -$666K | ﹤0.01% | 1375 |
|
2023
Q1 | $1.16M | Buy |
31,272
+27,676
| +770% | +$1.03M | ﹤0.01% | 1241 |
|
2022
Q4 | $148K | Sell |
3,596
-855
| -19% | -$35.3K | ﹤0.01% | 1552 |
|
2022
Q3 | $313K | Buy |
4,451
+3,602
| +424% | +$253K | ﹤0.01% | 1405 |
|
2022
Q2 | $51K | Buy |
+849
| New | +$51K | ﹤0.01% | 1533 |
|
2022
Q1 | – | Sell |
-72,330
| Closed | -$8.59M | – | 1711 |
|
2021
Q4 | $8.59M | Sell |
72,330
-3,525
| -5% | -$419K | 0.01% | 877 |
|
2021
Q3 | $13.4M | Sell |
75,855
-31,041
| -29% | -$5.49M | 0.01% | 769 |
|
2021
Q2 | $17.3M | Buy |
+106,896
| New | +$17.3M | 0.01% | 711 |
|